Telehealth Patients Experience a Significant Improvement in Care and Quality of Life
|
By HospiMedica International staff writers Posted on 17 Jun 2010 |
A new study has found that a telehealth system combining remote patient monitoring with motivational educational support tools improves the quality of life (QOL) of chronically ill heart failure patients.
Researchers at Hospital Germans Trias i Pujol (Badalona; Spain) reported the 12 months evaluation period results of 92 patients with severe heart failure at home participating in the CAtalan Remote Management Evaluation (CARME) study. The Philips Motiva interactive telehealth system was used to connect patients to their healthcare providers via their home television and a broadband internet connection. Patients were randomly assigned to two groups; the first received care plan-driven educational videos, motivational messages, and questionnaires. The second group received the same information but was also requested to monitor their blood pressure, pulse rate, and weight.
The results of the study showed a decrease of 68% in heart failure related hospitalizations and a reduction of days spent in hospital by 73%. The study also revealed that the patients showed a continuous and significant improvement in their perception of QOL over the 12-month observation period, an improvement that ranged from 62% to 72%. A postanalysis of the results showed that while at the beginning of the study 56% of the patients said that their QOL was "medium” or "low,” this number decreased to 22% at the end of the study. Also, the number of patients that considered their quality of life to be "medium-high” rose from 44% at the beginning of the study to 78% after one year, and more than one-quarter of respondents (28%) considered QOL to be "almost excellent.”
In addition, satisfaction with the telemonitoring system was high, especially in those patients who had vital measurements added to their educational and motivational tools. Up to 81% of these patients wanted to keep the solution in addition to their regular care. The results of the CARME study were presented at the European Society of Cardiology Heart Failure Congress, held during May-June 2010 in Berlin (Germany).
"The concept of providing educational support to heart failure patients via their television has significantly contributed to empowering them. Equally important, the CARME study has shown that disseminating patient and disease specific information via the TV, through Philips Motiva, helps family members to gain a better understanding of how to support effectively their loved ones in coping with their disease. This appears to have a very strong impact on outcomes,” said lead author Josep Lupon, M.D., head of the heart failure unit.
The Philips Motiva interactive telehealth system is a product of Phillips Healthcare (Best, The Netherlands).
Related Links:
Hospital Germans Trias i Pujol
Phillips Healthcare
Researchers at Hospital Germans Trias i Pujol (Badalona; Spain) reported the 12 months evaluation period results of 92 patients with severe heart failure at home participating in the CAtalan Remote Management Evaluation (CARME) study. The Philips Motiva interactive telehealth system was used to connect patients to their healthcare providers via their home television and a broadband internet connection. Patients were randomly assigned to two groups; the first received care plan-driven educational videos, motivational messages, and questionnaires. The second group received the same information but was also requested to monitor their blood pressure, pulse rate, and weight.
The results of the study showed a decrease of 68% in heart failure related hospitalizations and a reduction of days spent in hospital by 73%. The study also revealed that the patients showed a continuous and significant improvement in their perception of QOL over the 12-month observation period, an improvement that ranged from 62% to 72%. A postanalysis of the results showed that while at the beginning of the study 56% of the patients said that their QOL was "medium” or "low,” this number decreased to 22% at the end of the study. Also, the number of patients that considered their quality of life to be "medium-high” rose from 44% at the beginning of the study to 78% after one year, and more than one-quarter of respondents (28%) considered QOL to be "almost excellent.”
In addition, satisfaction with the telemonitoring system was high, especially in those patients who had vital measurements added to their educational and motivational tools. Up to 81% of these patients wanted to keep the solution in addition to their regular care. The results of the CARME study were presented at the European Society of Cardiology Heart Failure Congress, held during May-June 2010 in Berlin (Germany).
"The concept of providing educational support to heart failure patients via their television has significantly contributed to empowering them. Equally important, the CARME study has shown that disseminating patient and disease specific information via the TV, through Philips Motiva, helps family members to gain a better understanding of how to support effectively their loved ones in coping with their disease. This appears to have a very strong impact on outcomes,” said lead author Josep Lupon, M.D., head of the heart failure unit.
The Philips Motiva interactive telehealth system is a product of Phillips Healthcare (Best, The Netherlands).
Related Links:
Hospital Germans Trias i Pujol
Phillips Healthcare
Latest Health IT News
- Voice-Driven AI System Enables Structured GI Procedure Documentation
- EMR-Based Tool Predicts Graft Failure After Kidney Transplant
- Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
- Smartwatches Could Detect Congestive Heart Failure
- Versatile Smart Patch Combines Health Monitoring and Drug Delivery
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read moreSurgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreBusiness
view channel







